Molecular Partners AG American Depositary Shares
Symbol: MOLN (NASDAQ)
4.16
▼ (-2.81%) -0.120
Company Description:
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
Key Stats
- Today's Open: $4.293
- Today's High: $4.293
- Today's Low: $4.155
- Today's Volume: 757
- Yesterday Close: $4.275
- Yesterday High: $4.275
- Yesterday Low: $4.0412
- Yesterday Volume: 1.53K
- Last Min Volume: 150
- Last Min High: $4.155
- Last Min Low: $4.155
- Last Min VWAP: $4.155
Company Profile
- Name: Molecular Partners AG American Depositary Shares
- Website: https://www.molecularpartners.com
- Listed Date: 2021-06-16
- Location: ,
- Market Status: Active
- CIK Number: 0001745114
- SIC Code:
- SIC description:
- Market Cap: $150.45M
- Round Lot: 100
- Outstanding Shares: 36.87M
- Asset Type: ADRC
RECENT FILINGS FOR MOLN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-05-02 | SCHEDULE 13G | View |
| 2025-04-29 | 6-K | View |
| 2025-04-24 | EFFECT | View |
| 2025-04-11 | F-3 | View |
| 2025-03-06 | 6-K | View |
| 2025-03-06 | 6-K | View |
| 2025-03-06 | 20-F | View |
| 2025-01-13 | 6-K | View |
| 2025-01-13 | 6-K | View |
| 2024-10-31 | 6-K | View |
| 2024-10-29 | SC 13D/A | View |
| 2024-10-28 | 6-K | View |
| 2024-10-25 | 424B5 | View |
| 2024-10-22 | 6-K | View |
| 2024-08-26 | 6-K | View |
| 2024-06-26 | S-8 | View |
| 2024-06-14 | 6-K | View |
| 2024-06-11 | 6-K | View |
| 2024-06-03 | 6-K | View |
| 2024-05-17 | 6-K/A | View |
Latest News on MOLN